Chong-xian Pan - Publications, H-index & Citations

Chong-xian Pan

VA Boston Healthcare System

36H指数

292论文数

5.8K被引数

收录论文 56

发表时间

Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer I期首次人体剂量递增试验：一种膀胱癌特异性纳米颗粒在非肌层浸润性膀胱癌中的应用

Nanomedicine

IF3.9

2026-07-08

PREAI

Chong-Xian Pan; Matthew Mossanen; Jeffrey L Ellis; Ai-Hong Ma; Chun Yang; Hizra Farrukh; Yanxiao Jiao; Urvashi Bhardwaj; Joyce S. Lee; Primo N. Lara; Colleen Hynes; Tzu-Yin Lin; Yuanpei Li; Lori Lerner; Mark A. Preston; Adam Kibel; Marc Dall’Era; Kit S. Lam

A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non–muscle-invasive bladder cancer PLZ4包被的紫杉醇负载胶束在难治性非肌层浸润性膀胱癌患者中的I期临床试验

Nanomedicine

IF3.9

2026-06-01

OAAI

Athira Narayan; Ryan C. Leibrandt; Joyce S. Lee; Marc A. Dall’Era; Jared M. Whitson; Thenappan Chandrasekar; Avery Braun; Matthew Mossanen; Hong Li; Primo N. Lara Jr; Kit S. Lam; Chong-Xian Pan; Mamta Parikh

Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway 通过靶向PI3K和IGFR通路，在治疗携带PI3K通路激活性改变的肺癌中产生协同效应

Translational Oncology

IF4.1

2026-04-03

OAAI

Mohamed Abd El-Salam; Wu Chen; Yan Tang; Ting Rao; Xuejia Kang; Lifang Sun; Tiegang Han; Pengyu Chen; Matthew Mossanen; Fan Cheng; Chun Yang; Chong-Xian Pan

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

CANCER RESEARCH

IF16.6

2024-07-02

OAAI

White, Brian S.; Woo, Xing Yi; Koc, Soner; Sheridan, Todd; Neuhauser, Steven B.; Wang, Shidan; Evrard, Yvonne A.; Chen, Li; Pour, Ali Foroughi; Landua, John D.; Mashl, R. Jay; Davies, Sherri R.; Fang, Bingliang; Rosa, Maria Gabriela; Evans, Kurt W.; Bailey, Matthew H.; Chen, Yeqing; Xiao, Min; Rubinstein, Jill C.; Sanderson, Brian J.; Lloyd, Michael W.; Domanskyi, Sergii; Dobrolecki, Lacey E.; Fujita, Maihi; Fujimoto, Junya; Xiao, Guanghua; Fields, Ryan C.; Mudd, Jacqueline L.; Xu, Xiaowei; Hollingshead, Melinda G.; Jiwani, Shahanawaz; Acevedo, Saul; Davis-Dusenbery, Brandi N.; Robinson, Peter N.; Moscow, Jeffrey A.; Doroshow, James H.; Mitsiades, Nicholas; Kaochar, Salma; Pan, Chong-xian; Carvajal-Carmona, Luis G.; Welm, Alana L.; Welm, Bryan E.; Govindan, Ramaswamy; Li, Shunqiang; Davies, Michael A.; Roth, Jack A.; Meric-Bernstam, Funda; Xie, Yang; Herlyn, Meenhard; Ding, Li; Lewis, Michael T.; Bult, Carol J.; Dean II, Dennis A.; Chuang, Jeffrey H.

A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers

BIOMATERIALS

IF12.9

2023-08-01

PREAI

Xue, Xiangdong; Qu, Haijing; Bo, Ruonan; Zhang, Dalin; Zhu, Zheng; Xiang, Bai; Li, Longmeng; Ricci, Marina; Pan, Chong-Xian; Lin, Tzu-Yin; Li, Yuanpei

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

SCIENTIFIC REPORTS

IF3.9

2023-06-14

OAAI

Steele, Thomas M.; Tsamouri, Maria Malvina; Siddiqui, Salma; Lucchesi, Christopher A.; Vasilatis, Demitria; Mooso, Benjamin A.; Durbin-Johnson, Blythe P.; Ma, Ai-Hong; Hejazi, Nazila; Parikh, Mamta; Mudryj, Maria; Pan, Chong-Xian; Ghosh, Paramita M.

Increasing cure rates of solid tumors by immune checkpoint inhibitors 通过免疫检查点抑制剂提高实体瘤的治愈率

hematology oncology

IF13.5

2023-01-16

OAAI

Ma, Weijie; Xue, Ruobing; Zhu, Zheng; Farrukh, Hizra; Song, Wenru; Li, Tianhong; Zheng, Lei; Pan, Chong-xian

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors

JCI INSIGHT

IF6.1

2022-08-22

OAAI

Rehman, Hasibur; Chandrashekar, Darshan S.; Balabhadrapatruni, Chakravarthi; Nepal, Saroj; Balasubramanya, Sai Akshaya Hodigere; Shelton, Abigail K.; Skinner, Kasey R.; Ma, Ai-Hong; Rao, Ting; Agarwal, Sumit; Eich, Marie-Lisa; Robinson, Alyncia D.; Naik, Gurudatta; Manne, Upender; Netto, George J.; Miller, C. Ryan; Pan, Chong-Xian; Sonpavde, Guru; Varambally, Sooryanarayana; Ferguson, James E., III

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy 汽车竞赛到癌症免疫疗法: 从CAR T，CAR NK到CAR巨噬细胞疗法

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-03-31

322

OAAI

Pan, Kevin; Farrukh, Hizra; Chittepu, Veera Chandra Sekhar Reddy; Xu, Huihong; Pan, Chong-xian; Zhu, Zheng

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-01

OAAI

Zhu, Shaoming; Ma, A-Hong; Zhu, Zheng; Adib, Elio; Rao, Ting; Li, Na; Ni, Kaiyuan; Chittepu, Veera Chandra Sekhar Reddy; Prabhala, Rao; Risco, Juan Garisto; Kwiatkowski, David; Mouw, Kent; Sonpavde, Guru; Cheng, Fan; Pan, Chong-Xian

Combination strategies to maximize the benefits of cancer immunotherapy 最大化癌症免疫疗法益处的组合策略

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2021-09-27

328

OAAI

Zhu, Shaoming; Zhang, Tian; Zheng, Lei; Liu, Hongtao; Song, Wenru; Liu, Delong; Li, Zihai; Pan, Chong-xian

Novel strategies for immuno-oncology breakthroughs with cell therapy

BIOMARKER RESEARCH

IF11.5

2021-07-31

OAAI

Liu, Hongtao; Pan, Chongxian; Song, Wenru; Liu, Delong; Li, Zihai; Zheng, Lei

Novel Nanococktail of a Dual PI3K/mTOR Inhibitor and Cabazitaxel for Castration-Resistant Prostate Cancer

ADVANCED THERAPEUTICS

IF2.6

2020-06-30

OAAI

Huang, Yee; Xue, Xiangdong; Li, Xiaocen; Jia, Bei; Pan, Chong-Xian; Li, Yuanpei; Lin, Tzu-Yin

Self-Assembled Nanoparticle-Mediated Chemophototherapy Reverses the Drug Resistance of Bladder Cancers through Dual AKT/ERK Inhibition

ADVANCED THERAPEUTICS

IF2.6

2020-05-19

PREAI

Yu, Weimin; Xue, Xiangdong; Ma, Ai-Hong; Ruan, Yuan; Zhang, Hongyong; Cheng, Fan; Li, Yuanpei; Pan, Chong-Xian; Lin, Tzu-Yin

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2020-04-03

179

OAAI

Pan, Chongxian; Liu, Hongtao; Robins, Elizabeth; Song, Wenru; Liu, Delong; Li, Zihai; Zheng, Lei

Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks 患者衍生癌症模型和下一代生物库的条件重编程

CELLS

IF5.2

2019-10-27

OAAI

Palechor-Ceron, Nancy; Krawczyk, Ewa; Dakic, Aleksandra; Simic, Vera; Yuan, Hang; Blancato, Jan; Wang, Weisheng; Hubbard, Fleesie; Zheng, Yun-Ling; Dan, Hancai; Strome, Scott; Cullen, Kevin; Davidson, Bruce; Deeken, John F.; Choudhury, Sujata; Ahn, Peter H.; Agarwal, Seema; Zhou, Xuexun; Schlegel, Richard; Furth, Priscilla A.; Pan, Chong-Xian; Liu, Xuefeng

Microdose induced oxaliplatin-DNA adducts as a predictive biomarker of response in colorectal cancer

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Chen, Justin; Cho, May; Zimmermann, Maike; Semrad, Thomas; Wu, Chun-Yi; Yu, Aiming; Pan, Chong-Xian; Henderson, Paul T.; Kim, Edward J.

A patient-derived xenograft (PDX) platform for cancer translational, precision medicine and health disparity research

CANCER RESEARCH

IF16.6

2019-07-01

OAAI

Pan, Chong-Xian; Zhang, Hongyong; Ma, Ai-Hong; Zeng, Shuxiong; Zimmermann, Maike; Tepper, Clifford; Henderson, Paul; Carvajal-Carmona, Luis; Gandour-Edwards, Regina; Chen, Moon; Airhart, Susan; Whtie, Ralph de Vere

Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy 人源化小鼠研究PD-1-targeted肿瘤免疫治疗的疗效和机制

FASEB JOURNAL

IF4.2

2018-01-03

254

OAAI

Wang, Minan; Yao, Li-Chin; Cheng, Mingshan; Cai, Danying; Martinek, Jan; Pan, Chong-Xian; Shi, Wei; Ma, Ai-Hong; White, Ralph W. De Vere; Airhart, Susan; Liu, Edison T.; Banchereau, Jacques; Brehm, Michael A.; Greiner, Dale L.; Shultz, Leonard D.; Palucka, Karolina; Keck, James G.

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2017-08-02

OAAI

Liu, Chengfei; Armstrong, Cameron M.; Lou, Wei; Lombard, Alan P.; Cucchiara, Vito; Gu, Xinwei; Yang, Joy C.; Nadiminty, Nagalakshmi; Pan, Chong-xian; Evans, Christopher P.; Gao, Allen C.

研究方向